NOX 0.00% 10.0¢ noxopharm limited

Ann: Noxopharm Secures Key European Patent Allowance for Veyonda, page-30

  1. 593 Posts.
    lightbulb Created with Sketch. 359
    Bad news in the long suffering USPTO RADIOTHERAPY IMPROVEMENTS application, with another non-final rejection recently.

    This particular examiner has a real stick up his arse; seems like NOX might need to go around him to pursue this one.

    At least this gave me a good laugh.... A beautiful example of the kafkaesque mindset of the will-sapping jobsworth pedants that make everything in this world just a little bit worse:

    https://hotcopper.com.au/data/attachments/3381/3381938-2123d2930f49d6a8d8fecac1819e53a4.jpg

    Parents, don't let your children grow up to be patent examiners.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.